aluates Reports

$ 0.0

Automative

Global Orally Disintegrating Drug Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-8B14826

Global Orally Disintegrating Drug Market Research Report 2023

BUY CHAPTERS

Global Orally Disintegrating Drug Market Research Report 2025

Code: QYRE-Auto-8B14826

Report

May 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson and Johnson

GSK

Otsuka

TEVA

Pfizer Inc

Eli Lilly and Company

Merck

Eisai Co Ltd

Astrazeneca plc

Bristol–Myers Squibb

Conquer

Vartris

Orally Disintegrating Drug Market Size

The global market for Orally Disintegrating Drug was valued at US$ 2336 million in the year 2024 and is projected to reach a revised size of US$ 4371 million by 2031, growing at a CAGR of 9.5% during the forecast period.

Orally Disintegrating Drug Market

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

The orally disintegrating drug market is being driven by several factors. One of the primary drivers is the growing demand for convenient and patient-friendly medication delivery methods. Orally disintegrating drugs offer an advantage over traditional oral tablets as they quickly dissolve in the mouth without the need for water, making them easier to administer, particularly for individuals with swallowing difficulties, pediatric patients, and the elderly. Additionally, the increasing prevalence of chronic diseases and the need for efficient and immediate drug absorption have fueled the demand for orally disintegrating drugs. Furthermore, advancements in formulation technologies and taste-masking techniques have improved the palatability of these drugs, enhancing patient compliance. Overall, the demand for orally disintegrating drugs is driven by the need for convenience, improved patient experience, and enhanced drug delivery options in the pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Drug.

The Orally Disintegrating Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orally Disintegrating Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Orally Disintegrating Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Orally Disintegrating Drug Market Report

Report Metric	Details
Report Name	Orally Disintegrating Drug Market
Accounted market size in year	US$ 2336 million
Forecasted market size in 2031	US$ 4371 million
CAGR	9.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Anti-Psychotics Drug Anti-Epileptics Drug Other
Segment by Application	CNS Diseases Gastrointestinal Diseases CVS Diseases Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson and Johnson, GSK, Otsuka, Vartris, Teva, Pfizer, Eli Lilly and Company, Merck, Eisai, AstraZeneca, Bristol-Myers Squibb, Conquer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Orally Disintegrating Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Orally Disintegrating Drug Market growing?

Ans: The Orally Disintegrating Drug Market witnessing a CAGR of 9.5% during the forecast period 2025-2031.

What is the Orally Disintegrating Drug Market size in 2031?

Ans: The Orally Disintegrating Drug Market size in 2031 will be US$ 4371 million.

Who are the main players in the Orally Disintegrating Drug Market report?

Ans: The main players in the Orally Disintegrating Drug Market are Johnson and Johnson, GSK, Otsuka, Vartris, Teva, Pfizer, Eli Lilly and Company, Merck, Eisai, AstraZeneca, Bristol-Myers Squibb, Conquer

What are the Application segmentation covered in the Orally Disintegrating Drug Market report?

Ans: The Applications covered in the Orally Disintegrating Drug Market report are CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Other

What are the Type segmentation covered in the Orally Disintegrating Drug Market report?

Ans: The Types covered in the Orally Disintegrating Drug Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Other

Recommended Reports

Oral Drug Delivery

Oral Tablet Technologies

Oral Disease Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Orally Disintegrating Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Anti-Psychotics Drug

1.2.3 Anti-Epileptics Drug

1.2.4 Other

1.3 Market by Application

1.3.1 Global Orally Disintegrating Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 CNS Diseases

1.3.3 Gastrointestinal Diseases

1.3.4 CVS Diseases

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Orally Disintegrating Drug Market Perspective (2020-2031)

2.2 Global Orally Disintegrating Drug Growth Trends by Region

2.2.1 Global Orally Disintegrating Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Orally Disintegrating Drug Historic Market Size by Region (2020-2025)

2.2.3 Orally Disintegrating Drug Forecasted Market Size by Region (2026-2031)

2.3 Orally Disintegrating Drug Market Dynamics

2.3.1 Orally Disintegrating Drug Industry Trends

2.3.2 Orally Disintegrating Drug Market Drivers

2.3.3 Orally Disintegrating Drug Market Challenges

2.3.4 Orally Disintegrating Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Orally Disintegrating Drug Players by Revenue

3.1.1 Global Top Orally Disintegrating Drug Players by Revenue (2020-2025)

3.1.2 Global Orally Disintegrating Drug Revenue Market Share by Players (2020-2025)

3.2 Global Orally Disintegrating Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Orally Disintegrating Drug Revenue

3.4 Global Orally Disintegrating Drug Market Concentration Ratio

3.4.1 Global Orally Disintegrating Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Orally Disintegrating Drug Revenue in 2024

3.5 Global Key Players of Orally Disintegrating Drug Head office and Area Served

3.6 Global Key Players of Orally Disintegrating Drug, Product and Application

3.7 Global Key Players of Orally Disintegrating Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Orally Disintegrating Drug Breakdown Data by Type

4.1 Global Orally Disintegrating Drug Historic Market Size by Type (2020-2025)

4.2 Global Orally Disintegrating Drug Forecasted Market Size by Type (2026-2031)

5 Orally Disintegrating Drug Breakdown Data by Application

5.1 Global Orally Disintegrating Drug Historic Market Size by Application (2020-2025)

5.2 Global Orally Disintegrating Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Orally Disintegrating Drug Market Size (2020-2031)

6.2 North America Orally Disintegrating Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Orally Disintegrating Drug Market Size by Country (2020-2025)

6.4 North America Orally Disintegrating Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Orally Disintegrating Drug Market Size (2020-2031)

7.2 Europe Orally Disintegrating Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Orally Disintegrating Drug Market Size by Country (2020-2025)

7.4 Europe Orally Disintegrating Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Orally Disintegrating Drug Market Size (2020-2031)

8.2 Asia-Pacific Orally Disintegrating Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Orally Disintegrating Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Orally Disintegrating Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Orally Disintegrating Drug Market Size (2020-2031)

9.2 Latin America Orally Disintegrating Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Orally Disintegrating Drug Market Size by Country (2020-2025)

9.4 Latin America Orally Disintegrating Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Orally Disintegrating Drug Market Size (2020-2031)

10.2 Middle East & Africa Orally Disintegrating Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Orally Disintegrating Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Orally Disintegrating Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson and Johnson

11.1.1 Johnson and Johnson Company Details

11.1.2 Johnson and Johnson Business Overview

11.1.3 Johnson and Johnson Orally Disintegrating Drug Introduction

11.1.4 Johnson and Johnson Revenue in Orally Disintegrating Drug Business (2020-2025)

11.1.5 Johnson and Johnson Recent Development

11.2 GSK

11.2.1 GSK Company Details

11.2.2 GSK Business Overview

11.2.3 GSK Orally Disintegrating Drug Introduction

11.2.4 GSK Revenue in Orally Disintegrating Drug Business (2020-2025)

11.2.5 GSK Recent Development

11.3 Otsuka

11.3.1 Otsuka Company Details

11.3.2 Otsuka Business Overview

11.3.3 Otsuka Orally Disintegrating Drug Introduction

11.3.4 Otsuka Revenue in Orally Disintegrating Drug Business (2020-2025)

11.3.5 Otsuka Recent Development

11.4 Vartris

11.4.1 Vartris Company Details

11.4.2 Vartris Business Overview

11.4.3 Vartris Orally Disintegrating Drug Introduction

11.4.4 Vartris Revenue in Orally Disintegrating Drug Business (2020-2025)

11.4.5 Vartris Recent Development

11.5 Teva

11.5.1 Teva Company Details

11.5.2 Teva Business Overview

11.5.3 Teva Orally Disintegrating Drug Introduction

11.5.4 Teva Revenue in Orally Disintegrating Drug Business (2020-2025)

11.5.5 Teva Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Orally Disintegrating Drug Introduction

11.6.4 Pfizer Revenue in Orally Disintegrating Drug Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Eli Lilly and Company

11.7.1 Eli Lilly and Company Company Details

11.7.2 Eli Lilly and Company Business Overview

11.7.3 Eli Lilly and Company Orally Disintegrating Drug Introduction

11.7.4 Eli Lilly and Company Revenue in Orally Disintegrating Drug Business (2020-2025)

11.7.5 Eli Lilly and Company Recent Development

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Orally Disintegrating Drug Introduction

11.8.4 Merck Revenue in Orally Disintegrating Drug Business (2020-2025)

11.8.5 Merck Recent Development

11.9 Eisai

11.9.1 Eisai Company Details

11.9.2 Eisai Business Overview

11.9.3 Eisai Orally Disintegrating Drug Introduction

11.9.4 Eisai Revenue in Orally Disintegrating Drug Business (2020-2025)

11.9.5 Eisai Recent Development

11.10 AstraZeneca

11.10.1 AstraZeneca Company Details

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Orally Disintegrating Drug Introduction

11.10.4 AstraZeneca Revenue in Orally Disintegrating Drug Business (2020-2025)

11.10.5 AstraZeneca Recent Development

11.11 Bristol-Myers Squibb

11.11.1 Bristol-Myers Squibb Company Details

11.11.2 Bristol-Myers Squibb Business Overview

11.11.3 Bristol-Myers Squibb Orally Disintegrating Drug Introduction

11.11.4 Bristol-Myers Squibb Revenue in Orally Disintegrating Drug Business (2020-2025)

11.11.5 Bristol-Myers Squibb Recent Development

11.12 Conquer

11.12.1 Conquer Company Details

11.12.2 Conquer Business Overview

11.12.3 Conquer Orally Disintegrating Drug Introduction

11.12.4 Conquer Revenue in Orally Disintegrating Drug Business (2020-2025)

11.12.5 Conquer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Johnson and Johnson

GSK

Otsuka

TEVA

Pfizer Inc

Eli Lilly and Company

Merck

Eisai Co Ltd

Astrazeneca plc

Bristol–Myers Squibb

Conquer

Vartris

List of Tables

Table 1. Global Orally Disintegrating Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Anti-Psychotics Drug

Table 3. Key Players of Anti-Epileptics Drug

Table 4. Key Players of Other

Table 5. Global Orally Disintegrating Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Orally Disintegrating Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Orally Disintegrating Drug Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Orally Disintegrating Drug Market Share by Region (2020-2025)

Table 9. Global Orally Disintegrating Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Orally Disintegrating Drug Market Share by Region (2026-2031)

Table 11. Orally Disintegrating Drug Market Trends

Table 12. Orally Disintegrating Drug Market Drivers

Table 13. Orally Disintegrating Drug Market Challenges

Table 14. Orally Disintegrating Drug Market Restraints

Table 15. Global Orally Disintegrating Drug Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Orally Disintegrating Drug Market Share by Players (2020-2025)

Table 17. Global Top Orally Disintegrating Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Drug as of 2024)

Table 18. Ranking of Global Top Orally Disintegrating Drug Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Orally Disintegrating Drug Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Orally Disintegrating Drug, Headquarters and Area Served

Table 21. Global Key Players of Orally Disintegrating Drug, Product and Application

Table 22. Global Key Players of Orally Disintegrating Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Orally Disintegrating Drug Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Orally Disintegrating Drug Revenue Market Share by Type (2020-2025)

Table 26. Global Orally Disintegrating Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Orally Disintegrating Drug Revenue Market Share by Type (2026-2031)

Table 28. Global Orally Disintegrating Drug Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Orally Disintegrating Drug Revenue Market Share by Application (2020-2025)

Table 30. Global Orally Disintegrating Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Orally Disintegrating Drug Revenue Market Share by Application (2026-2031)

Table 32. North America Orally Disintegrating Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Orally Disintegrating Drug Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Orally Disintegrating Drug Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Orally Disintegrating Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Orally Disintegrating Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Orally Disintegrating Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Orally Disintegrating Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Orally Disintegrating Drug Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Orally Disintegrating Drug Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Orally Disintegrating Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Orally Disintegrating Drug Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Orally Disintegrating Drug Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Orally Disintegrating Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Orally Disintegrating Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Orally Disintegrating Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Johnson and Johnson Company Details

Table 48. Johnson and Johnson Business Overview

Table 49. Johnson and Johnson Orally Disintegrating Drug Product

Table 50. Johnson and Johnson Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 51. Johnson and Johnson Recent Development

Table 52. GSK Company Details

Table 53. GSK Business Overview

Table 54. GSK Orally Disintegrating Drug Product

Table 55. GSK Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 56. GSK Recent Development

Table 57. Otsuka Company Details

Table 58. Otsuka Business Overview

Table 59. Otsuka Orally Disintegrating Drug Product

Table 60. Otsuka Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 61. Otsuka Recent Development

Table 62. Vartris Company Details

Table 63. Vartris Business Overview

Table 64. Vartris Orally Disintegrating Drug Product

Table 65. Vartris Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 66. Vartris Recent Development

Table 67. Teva Company Details

Table 68. Teva Business Overview

Table 69. Teva Orally Disintegrating Drug Product

Table 70. Teva Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 71. Teva Recent Development

Table 72. Pfizer Company Details

Table 73. Pfizer Business Overview

Table 74. Pfizer Orally Disintegrating Drug Product

Table 75. Pfizer Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 76. Pfizer Recent Development

Table 77. Eli Lilly and Company Company Details

Table 78. Eli Lilly and Company Business Overview

Table 79. Eli Lilly and Company Orally Disintegrating Drug Product

Table 80. Eli Lilly and Company Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 81. Eli Lilly and Company Recent Development

Table 82. Merck Company Details

Table 83. Merck Business Overview

Table 84. Merck Orally Disintegrating Drug Product

Table 85. Merck Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 86. Merck Recent Development

Table 87. Eisai Company Details

Table 88. Eisai Business Overview

Table 89. Eisai Orally Disintegrating Drug Product

Table 90. Eisai Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 91. Eisai Recent Development

Table 92. AstraZeneca Company Details

Table 93. AstraZeneca Business Overview

Table 94. AstraZeneca Orally Disintegrating Drug Product

Table 95. AstraZeneca Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 96. AstraZeneca Recent Development

Table 97. Bristol-Myers Squibb Company Details

Table 98. Bristol-Myers Squibb Business Overview

Table 99. Bristol-Myers Squibb Orally Disintegrating Drug Product

Table 100. Bristol-Myers Squibb Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 101. Bristol-Myers Squibb Recent Development

Table 102. Conquer Company Details

Table 103. Conquer Business Overview

Table 104. Conquer Orally Disintegrating Drug Product

Table 105. Conquer Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)

Table 106. Conquer Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Orally Disintegrating Drug Picture

Figure 2. Global Orally Disintegrating Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Orally Disintegrating Drug Market Share by Type: 2024 VS 2031

Figure 4. Anti-Psychotics Drug Features

Figure 5. Anti-Epileptics Drug Features

Figure 6. Other Features

Figure 7. Global Orally Disintegrating Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Orally Disintegrating Drug Market Share by Application: 2024 VS 2031

Figure 9. CNS Diseases Case Studies

Figure 10. Gastrointestinal Diseases Case Studies

Figure 11. CVS Diseases Case Studies

Figure 12. Other Case Studies

Figure 13. Orally Disintegrating Drug Report Years Considered

Figure 14. Global Orally Disintegrating Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Orally Disintegrating Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Orally Disintegrating Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Orally Disintegrating Drug Market Share by Players in 2024

Figure 18. Global Top Orally Disintegrating Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Orally Disintegrating Drug Revenue in 2024

Figure 20. North America Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Orally Disintegrating Drug Market Share by Country (2020-2031)

Figure 22. United States Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Orally Disintegrating Drug Market Share by Country (2020-2031)

Figure 26. Germany Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Orally Disintegrating Drug Market Share by Region (2020-2031)

Figure 34. China Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Orally Disintegrating Drug Market Share by Country (2020-2031)

Figure 42. Mexico Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Orally Disintegrating Drug Market Share by Country (2020-2031)

Figure 46. Turkey Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Johnson and Johnson Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 50. GSK Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 51. Otsuka Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 52. Vartris Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 53. Teva Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 55. Eli Lilly and Company Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 56. Merck Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 57. Eisai Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 58. AstraZeneca Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 60. Conquer Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Orally Disintegrating Tablets Market Research Report 2024

Global Orally Disintegrating Tablet Excipient Market Insights Forecast to 2030

Orally Dissolving Tablets ODT Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mouth dissolving Tablets Market Insights Forecast to 2030

Global Fast disintegrating Tablets Market Insights Forecast to 2030

Global Rapid dissolving Tablets Market Insights Forecast to 2030

Global Orally Disintegrating Tablets ODT Platform Market Research Report 2024

Global Fast dissolving Tablets Market Insights Forecast to 2030

Global Orally Disintegrating Tablet Technology Market Research Report 2024

Global Orodispersible Tablets Market Insights Forecast to 2030

Global Excipients for Orally Disintegrating Tablets ODT Market Research Report 2024

Global Oral Disintegrating Strips Market Research Report 2024

Global Freeze Dried Orally Disintegrating Tablets Market Research Report 2024

Global Oral Solid Dosage Medicine Market Research Report 2025

Global Oral Fast Dissolving Film OFDF Market Research Report 2024

Global Orodispersible Film Market Research Report 2025

Global Aripiprazole Orally Disintegrating Tablets ODT Market Research Report 2025

Global Fast Melt Tablet Market Research Report 2024

Global Orally Disintegrating Films ODFs Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions